317 related articles for article (PubMed ID: 34193368)
21. Transabdominal ultrasonography: A non-invasive method for diagnosing vaginal atrophy.
Kanmaz AG; İnan AH; Beyan E; Budak A; Töz E; Alan M; Özeren M
Post Reprod Health; 2020 Dec; 26(4):220-226. PubMed ID: 32338147
[TBL] [Abstract][Full Text] [Related]
22. Pelvic floor muscle training as a treatment for genitourinary syndrome of menopause: A single-arm feasibility study.
Mercier J; Morin M; Zaki D; Reichetzer B; Lemieux MC; Khalifé S; Dumoulin C
Maturitas; 2019 Jul; 125():57-62. PubMed ID: 31133219
[TBL] [Abstract][Full Text] [Related]
23. [Short-term efficacy of vaginal CO
Kozma B; Póka R; Sipos A; Ács N; Takács P
Orv Hetil; 2019 Oct; 160(41):1617-1622. PubMed ID: 31587579
[TBL] [Abstract][Full Text] [Related]
24. Vulvovaginal atrophy of menopause and its impact on sexual function in an Italian clinical cohort of post-menopausal women.
Nappi RE; Guida M; Marchesoni D; Cianci A; Pellegrino A; Remorgida V; Di Paolantonio T; Benedetti Panici P;
J Obstet Gynaecol; 2021 Feb; 41(2):290-297. PubMed ID: 33432869
[TBL] [Abstract][Full Text] [Related]
25. Female sexuality and vaginal health across the menopausal age.
Cagnacci A; Venier M; Xholli A; Paglietti C; Caruso S;
Menopause; 2020 Jan; 27(1):14-19. PubMed ID: 31738734
[TBL] [Abstract][Full Text] [Related]
26. Effects of oxytocin versus promestriene on genitourinary syndrome: a pilot, prospective, randomized, double-blind study.
Santos LPA; Bonduki CE; Dardes RCM; Heinke T; Patriarca MT
Clinics (Sao Paulo); 2022; 77():100116. PubMed ID: 36194923
[TBL] [Abstract][Full Text] [Related]
27. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.
The NAMS 2020 GSM Position Statement Editorial Panel
Menopause; 2020 Sep; 27(9):976-992. PubMed ID: 32852449
[TBL] [Abstract][Full Text] [Related]
28. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study.
Palma F; Volpe A; Villa P; Cagnacci A;
Maturitas; 2016 Jan; 83():40-4. PubMed ID: 26421474
[TBL] [Abstract][Full Text] [Related]
29. Sexual Function in Women Suffering From Genitourinary Syndrome of Menopause Treated With Fractionated CO
Salvatore S; Pitsouni E; Del Deo F; Parma M; Athanasiou S; Candiani M
Sex Med Rev; 2017 Oct; 5(4):486-494. PubMed ID: 28843942
[TBL] [Abstract][Full Text] [Related]
30. Vaginal laser therapy for genitourinary syndrome of menopause - systematic review.
Mension E; Alonso I; Tortajada M; Matas I; Gómez S; Ribera L; Anglès S; Castelo-Branco C
Maturitas; 2022 Feb; 156():37-59. PubMed ID: 34217581
[TBL] [Abstract][Full Text] [Related]
31. The effect of pathophysiological changes in the vaginal milieu on the signs and symptoms of genitourinary syndrome of menopause (GSM).
Qi W; Li H; Wang C; Li H; Fan A; Han C; Xue F
Menopause; 2020 Aug; 28(1):102-108. PubMed ID: 32810079
[TBL] [Abstract][Full Text] [Related]
32. "Two wavelengths endovaginal laser system": Clinical evaluation of a new device for mild SUI and vaginal atrophy treatment.
Mezzana P
Dermatol Ther; 2020 Nov; 33(6):e14445. PubMed ID: 33098352
[TBL] [Abstract][Full Text] [Related]
33. Genitourinary syndrome of menopause: a systematic review on prevalence and treatment.
Mili N; Paschou SA; Armeni A; Georgopoulos N; Goulis DG; Lambrinoudaki I
Menopause; 2021 Mar; 28(6):706-716. PubMed ID: 33739315
[TBL] [Abstract][Full Text] [Related]
34. A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause.
Cruff J; Khandwala S
J Sex Med; 2021 Apr; 18(4):761-769. PubMed ID: 33757774
[TBL] [Abstract][Full Text] [Related]
35. Ultrasonographic measurement of vaginal thickness: Relation to menopausal status and genitourinary syndrome of menopause.
Türk S; Ertürk Coşkun AD; Vural F
J Obstet Gynaecol Res; 2022 Nov; 48(11):2911-2917. PubMed ID: 35896166
[TBL] [Abstract][Full Text] [Related]
36. Effect of Chamomile Vaginal Gel on the Sexual Function in Postmenopausal Women: A Double-Blind Randomized Controlled Trial.
Bosak Z; Iravani M; Moghimipour E; Haghighizadeh MH; Jelodarian P
J Sex Med; 2022 Jun; 19(6):983-994. PubMed ID: 35400624
[TBL] [Abstract][Full Text] [Related]
37. Improving the identification of genitourinary syndrome of menopause through the utilization of the Day-to-Day Impact of Vaginal Aging questionnaire.
Mastroianni J; Thompson JA; Shifren JL; Zuckerman AL; Pereira K
Menopause; 2020 Nov; 27(11):1295-1301. PubMed ID: 33110046
[TBL] [Abstract][Full Text] [Related]
38. CO
Athanasiou S; Pitsouni E; Falagas ME; Salvatore S; Grigoriadis T
Maturitas; 2017 Oct; 104():24-28. PubMed ID: 28923173
[TBL] [Abstract][Full Text] [Related]
39. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.
Gambacciani M; Levancini M; Cervigni M
Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987
[TBL] [Abstract][Full Text] [Related]
40. Genitourinary syndrome of menopause (GSM) and laser VEL: a review.
Elia D; Gambacciani M; Berreni N; Bohbot JM; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E
Horm Mol Biol Clin Investig; 2019 Dec; 41(1):. PubMed ID: 31855563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
